Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. (ELYM) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 34 transactions totaling $53.5M, demonstrating a bullish sentiment with $46.5M in net insider flow. The most recent transaction on Sep 20, 2024 involved a sale of 1,182 shares valued at $9.7K.
ELYM Insider Activity Summary
Who Is Buying ELYM Stock?
No significant insider buying has been recorded for ELYM in the recent period.
Who Is Selling ELYM Stock?
No significant insider selling has been recorded for ELYM in the recent period.
Is Eliem Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ELYM is bullish with an Insider Alignment Score of 94/100 and a net flow of $46.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ELYM Frequently Asked Questions
Understanding ELYM Insider Activity
Insider trading at Eliem Therapeutics, Inc. (ELYM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading ELYM stock, having executed 34 transactions in the past 90 days. The most active insider is Capital Nexus Fund Ii, L.p. Ra (Executive), who has made 6 transactions totaling $40.0M.
Related Tools
Track Eliem Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ELYM file new Form 4 transactions